| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253198C Medicinal composition for treating coronary heart disease and angina pectoris |
| 04/26/2006 | CN1253188C Medicine for treating hypertension and its preparing process |
| 04/26/2006 | CN1253181C Pure Chinese medicine preparation for treating angiitis and preparation process thereof |
| 04/26/2006 | CN1253169C Chinese medicine composition for treating apoplexy and its preparation method |
| 04/26/2006 | CN1253161C Medicine for treating cerebrovascular disease |
| 04/26/2006 | CN1253159C Health product of compound propolis and preparing method |
| 04/26/2006 | CN1253156C Orally disintegrating tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 04/26/2006 | CN1253152C Single particle nano-garlicin micro-capsule, and its preparation method |
| 04/26/2006 | CN1253150C Xa factor inhibitor on its own and/or combined with platelet anti-aggegating agent |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034118 Isolation nucleic acids; genetic engineering |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034041 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034032 1,2,3-triazolo(4,5-d)pyrimidine compounds used to treat cardiovascular disorders |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/25/2006 | US7034017 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/25/2006 | US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034008 Unitary catheter drug delivery device for delivering polynucleotide to cardiac tissue of the patient, capable of modulating an electrical property of the heart, and designed to suppress K channels; electrode to detect position of the device within the patient |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7034001 Methods of therapy with thrombin derived peptides |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033776 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/25/2006 | CA2433035C Pharmaceutical compositions comprising amlodipine maleate |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 04/20/2006 | WO2006041974A1 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 04/20/2006 | WO2006041763A1 Renin inhibitors for treating transplantation induced diseases |
| 04/20/2006 | WO2006041205A1 Angiogenesis promoter |
| 04/20/2006 | WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/20/2006 | WO2006041158A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006041061A1 Cerebral infarction suppressant |
| 04/20/2006 | WO2006041046A1 Pyridine derivative |
| 04/20/2006 | WO2006040980A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 04/20/2006 | WO2006040914A1 Process for producing concentrate of unsaturated fatty acid |
| 04/20/2006 | WO2006040728A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 04/20/2006 | US20060084702 (2S)-2-ethylphenylpropionic acid derivative |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084135 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083757 Method for treating cardiac muscle disorders |
| 04/20/2006 | US20060083733 High-concentration preparation of soluble thrombomodulin |
| 04/20/2006 | US20060083715 Interferon beta-like molecules for treatment of stroke |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE20122564U1 Pharmaceutical formulation used for treating edema comprises high purity torsemide modification II |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2583845A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 04/20/2006 | CA2583092A1 Antiangiogenic calixarene-based peptide mimetics |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | CA2580862A1 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 04/20/2006 | CA2580271A1 Method for treating vasculitis |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1647555A1 The c-glycosylisoflavones having alkylaminoalkoxyl substituent, the preparation and the use of the same |
| 04/19/2006 | EP1647547A1 New hydrated crystalline forms of perindopril erbumine, process for the preparation thereof and pharmaceutical formulations containing these compounds |
| 04/19/2006 | EP1646390A1 A1 adenosine receptor antagonists |
| 04/19/2006 | EP1646373A2 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 04/19/2006 | EP1562573B1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1492569A4 Aqueous dispersible steryl ester compositions |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |